Researchers use nanoparticles to overcome treatment-resistant breast cancer

Researchers from the University of Cincinnati College of Medicine have developed RNA nanoparticles that show promise in overcoming treatment-resistant breast cancer. The team’s work was published in ACS Nano.  The researchers used a nanocarrier to target HER2-positive breast cancer and stop the production of a specific protein to prevent metastasis and render the cancer cells vulnerable to tamoxifen, a therapy for estrogen-driven cancer. Get the full story at our sister site, Drug Delivery Business News. The post Researchers use nanoparticles to overcome treatment-resistant breast cancer appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Drug-Device Combinations Oncology Pharmaceuticals Research & Development University of Cincinnati Source Type: news